Bulletin
Investor Alert

New York Markets Open in:

Minerva Neurosciences Inc.

NAS: NERV

GO
/marketstate/country/us

After Hours

/zigman2/quotes/201988204/composite

$

3.93

Change

0.00 0.00%

Volume

Volume 9,327

Nov 23, 2020, 7:53 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/201988204/composite

Previous close

$ 3.68

$ 3.93

Change

+0.25 +6.79%

Day low

Day high

$3.63

$3.95

Open
Open: 3.66

52 week low

52 week high

$1.81

$15.22

Open

Market cap

$157.04M

Average volume

408,406

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-0.54

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/nerv

MarketWatch News on NERV

  1. Minerva's stock indicated to resume trading down about 33% after trial of schizophrenia treatment disappoints

    8:48 a.m. May 29, 2020

    - Tomi Kilgore

  2. Minerva shares fall on failed depression drug trial

    3:07 p.m. Dec. 19, 2019

    - Jaimy Lee

  3. 2 Small Biotech Stocks Make Citi’s Top 5 List

    2:39 p.m. Sept. 17, 2019

    - Barron's Online

  4. Minerva Neurosciences stock up 37.8% on resuming trade following halt

    7:11 a.m. June 24, 2019

    - Ciara Linnane

  5. Minerva Neurosciences says trial of insomnia treatment met primary and key secondary goals

    6:32 a.m. June 24, 2019

    - Ciara Linnane

  6. Minerva Neurosciences stock halted for the news

    6:32 a.m. June 24, 2019

    - Ciara Linnane

  7. Minerva Neurosciences shares rise 5% on trial results for schizophrenia drug

    7:16 a.m. May 17, 2018

    - Emma Court

  8. Charting the Market

    9:36 p.m. June 2, 2017

    - Barron's Online

  9. Minerva shares up 3.3% premarket

    7:24 a.m. May 15, 2017

    - Ciara Linnane

  10. Minerva Neurosciences announces plans for Phase3 trial of schizophrenia treatment

    7:23 a.m. May 15, 2017

    - Ciara Linnane

  11. Charting the Market

    11:10 p.m. May 27, 2016

    - Barron's Online

  12. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/nerv

Other News on NERV

  1. Minerva Neurosciences share slumps despite Q3 earnings beat

    11:49 a.m. Nov. 2, 2020

    - Seeking Alpha

  2. 10-Q: MINERVA NEUROSCIENCES, INC.

    7:08 a.m. Nov. 2, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  3. Minerva Neurosciences: What Now?

    10:43 a.m. Aug. 9, 2020

    - Seeking Alpha

  4. Minerva Neurosciences +3% after Q2 beat

    8:40 a.m. Aug. 3, 2020

    - Seeking Alpha

  5. 10-Q: MINERVA NEUROSCIENCES, INC.

    6:03 a.m. Aug. 3, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  6. Coronavirus Roundtable - Still Some Dancing To Be Done

    5:30 a.m. June 5, 2020

    - Seeking Alpha

  7. MFGP, AAXN among premarket gainers

    8:18 a.m. June 1, 2020

    - Seeking Alpha

  8. ZS, AGEN, CGC and MGNX among midday movers

    11:43 a.m. May 29, 2020

    - Seeking Alpha

  9. Minerva's (-81%) roluperidone flunks schizophrenia study

    10:58 a.m. May 29, 2020

    - Seeking Alpha

  10. Top Ranked Momentum Stocks to Buy for May 26th

    10:41 a.m. May 26, 2020

    - Zacks.com

  11. Loading more headlines...
/news/pressrelease/company/us/nerv

Press Releases on NERV

  1. Loading more headlines...

Rates »

Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.